Cell type-dependent control of NF-Y activity by TGF-β

C Alabert,L Rogers,L Kahn,S Niellez,P Fafet,S Cerulis,J M Blanchard,R A Hipskind,M-L Vignais
DOI: https://doi.org/10.1038/sj.onc.1209385
IF: 8.756
2006-01-23
Oncogene
Abstract:Transforming growth factor β (TGF-β) is a pluripotent cytokine that regulates cell growth and differentiation in a cell type-dependent fashion. TGF-β exerts its effects through the activation of several signaling pathways. One involves membrane proximal events that lead to nuclear translocation of members of the Smad family of transcriptional regulators. TGF-β can also activate MAPK cascades. Here, we show that TGF-β induces nuclear translocation of the NF-YA subunit of the transcription factor NF-Y by a process that requires activation of the ERK cascade. This results in increased binding of endogenous NF-Y to chromatin and TGF-β-dependent transcriptional regulation of the NF-Y target gene cyclin A2. Interestingly, the kinetics of NF-YA relocalization differs between epithelial cells and fibroblasts. NIH3T3 fibroblasts show an elevated basal level of phosphorylated p38 and delayed nuclear accumulation of NF-YA after TGF-β treatment. In contrast, MDCK cells show low basal p38 activation, higher basal ERK phosphorylation and more rapid localization of NF-YA after induction. Thus, NF-Y activation by TGF-β1 involves ERK1/2 and potentially an interplay between MAPK pathways, thereby opening the possibility for finely tuned transcriptional regulation.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology
What problem does this paper attempt to address?